The Shaky Assumptions Behind Trump’s Over $500 Billion in Projected Drug Savings
President Donald Trump has promoted significant prescription drug savings, exceeding $500 billion over a decade, attributed to his administration’s policies. However, these projected savings appear largely aspirational, stemming from anticipated outcomes rather than concrete actions already implemented. A key policy, the "most favored nation" (MFN) approach, aims to align U.S. drug prices with those in … Read more